Skip to main content
    M

    MKS Instruments Inc (MKSI)

    Official site

    TECHNOLOGY • SCIENTIFIC & TECHNICAL INSTRUMENTS • NASDAQ

    $204.38
    -11.27 (-5.23%)

    Market Cap: $14.58B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    MKS Instruments Inc (MKSI) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect MKS Instruments (MKSI) to earn $14.83 per share in the fiscal year ending Dec 31, 2026, on revenue of $5.23B. Of 14 analysts, 12 rate the stock Buy or Strong Buy, 1 Hold and 1 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 10 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 14 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 86% of the ratings.

    RatingAnalystsShare
    Strong Buy321.4%
    Buy964.3%
    Hold17.1%
    Sell17.1%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    14

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 32.9% and revenue estimates rise 22.9%.

    Fiscal year ending Dec 31, 2026
    $14.83
    EPS consensus, revenue $5.23B
    Fiscal year ending Dec 31, 2027
    $19.71
    EPS consensus, revenue $6.43B
    Next report
    Feb 15, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$14.83$14.33 to $15.0513$5.23B$5.23B to $5.26B13
    Dec 31, 2027$19.71$18.00 to $21.2513$6.43B$6.23B to $6.65B14

    Quarterly Estimates

    The EPS consensus falls from $5.09 for the quarter ending Dec 31, 2026 to $4.48 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$5.09$4.02 to $5.5316$1.51B$1.32B to $1.59B15
    Mar 31, 2027$4.48$4.19 to $4.7413$1.51B$1.48B to $1.54B11

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 29 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 2026100
    Fiscal year ending Dec 31, 2027100
    Quarter ending Mar 31, 202790

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 12.9% from $13.13.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$14.83$13.15$13.15$13.13$13.13+12.9%
    Fiscal year ending Dec 31, 2027$19.71$17.62$17.55$17.50$17.50+12.6%
    Quarter ending Mar 31, 2027$4.48$3.87$3.88$3.87$3.87+15.7%

    Frequently Asked Questions About MKSI

    What is the MKSI stock forecast?

    Consensus analyst estimates put MKS Instruments's EPS at $14.83 for the fiscal year ending Dec 31, 2026, on revenue of $5.23B. The consensus rating from 14 analysts is Buy.

    How do analysts rate MKSI stock?

    Of 14 analysts covering MKS Instruments, 3 rate it Strong Buy, 9 Buy, 1 Hold, 1 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from MKSI next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $14.83, with estimates from $14.33 to $15.05 from 13 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $19.71, with estimates from $18.00 to $21.25 from 13 analysts.

    What revenue do analysts expect from MKS Instruments next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $5.23B, with estimates from $5.23B to $5.26B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $6.43B, with estimates from $6.23B to $6.65B.

    How many analysts cover MKSI?

    14 analysts rate MKS Instruments stock, and 13 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.